Ministry of Health says this August it will extend drug coverage for ALS patients to cover a treatment that typically costs users $120,000 annually. Approved by Health Canada in Oct. 2018, edavarone is an intravenous drug that reportedly improves the condition of people in the early stages of ALS. will continue to support ALS patients through its expansion of coverage of life-changing drugs and research funding to improve the lives of British Columbians." The government says this year it expects between 66 and 183 patients of an estimated 480 people in B.C. ALS centre of excellenceThe government has also pledged $1 million to match the same amount raised by the ALS Society of British Columbia for an ALS Centre of Excellence.

Source: CBC News August 14, 2020 20:27 UTC